Pharma and BioTech Daily Pharma and BioTech News

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. The FDA recently approved a biosimilar of Stelara from Alvotech and Teva, set to launch early next year. Johnson & Johnson reported mixed sales performance for new multiple myeloma drugs, with Tecvayli sales exceeding expectations and Carvykti underperforming. Roche also released survival data for a new lymphoma drug, potentially giving it an edge over a competit...

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in the Pharma and Biotech world.## Breakthrough in Cancer TreatmentScientists have discovered a new drug that has shown promising results in treating a rare form of cancer. The drug, which targets specific genetic mutations, has been successful in shrinking tumors in clinical trials. This breakthrough could potentially lead to more effective treatments for other types of cancer as well.## FDA ...

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.## Breakthrough in Cancer TreatmentA new study published in the Journal of Oncology has revealed a groundbreaking discovery in cancer treatment. Researchers have found a novel combination of drugs that have shown significant efficacy in targeting and destroying cancer cells. This new treatment approach has the potential to revolutionize the way we treat cancer patie...

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.## Breakthrough in Cancer TreatmentIn a groundbreaking study published in the Journal of Oncology, researchers have discovered a new combination therapy that has shown promising results in treating aggressive forms of cancer. The combination of targeted therapy and immunotherapy has significantly improved survival rates in patients with advanced stage tumors. This d...

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Private biotech funding is on the rise, with venture firms investing in cell therapy developments in cancer care. Century has acquired Clade Therapeutics and raised $60 million through a private placement led by Bain Capital to expand its cell therapy technology. In the first quarter of 2024, twenty-six drugmakers raised over $100 million each. The FDA has approved CA...

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Pfizer is planning to bring an RSV shot to adults aged 18-59, while Boehringer Ingelheim is facing staff layoffs due to biosimilar challenges. Amylyx made a rare move by pulling an ALS drug from the market. On the regulatory front, the FDA has approved CAR-T therapies from J&J and Bristol Myers for earlier use in myeloma patients. Sage's depression drugs are fac...